Introduzione
As defined by the EMA, "ePI refers to the authorized, regulatory product information for medicinal products (including the summary of product characteristics, package leaflet and labelling) adapted for handling in electronic format and distribution via the web, e-platforms and print".
This course aims to provide an overview of the latest developments within EU ePI, EMA's PLM portal and integration with other initiatives such as PMS / SPOR Master Data.
A high-level overview of the Fast Healthcare Interoperability Resources (FHIR) data exchange standard, the impact of ePI on pharmaceutical companies and an outline of three approaches for ePI approaches/implementation, including an analysis of their benefits vs. risks, will be covered.
In addition, the course will explore in more detail how to manage product information as an electronic data asset and how to use this information as an organization to gain business value.
This course will help you to understand and gain insight into the current landscape of ePI and other obligations.